Leif Carlsson

4.8k total citations · 1 hit paper
60 papers, 3.6k citations indexed

About

Leif Carlsson is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Leif Carlsson has authored 60 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Cardiology and Cardiovascular Medicine, 32 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Leif Carlsson's work include Cardiac electrophysiology and arrhythmias (44 papers), Ion channel regulation and function (23 papers) and Cardiac Arrhythmias and Treatments (19 papers). Leif Carlsson is often cited by papers focused on Cardiac electrophysiology and arrhythmias (44 papers), Ion channel regulation and function (23 papers) and Cardiac Arrhythmias and Treatments (19 papers). Leif Carlsson collaborates with scholars based in Sweden, United States and United Kingdom. Leif Carlsson's co-authors include Göran Duker, Stanley Nattel, Luc M. Hondeghem, Alice Davis, Russell Wallis, Peter K. S. Siegl, W. G. Lynch, Ian C. Mackenzie, Olle Almgren and Dobromir Dobrev and has published in prestigious journals such as Circulation, Nature Communications and Nature Reviews Drug Discovery.

In The Last Decade

Leif Carlsson

60 papers receiving 3.5k citations

Hit Papers

Relationships between preclinical cardiac electrophysiolo... 2003 2026 2010 2018 2003 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
    2003 1.2k citations Leif Carlsson, Alice Davis et al. Cardiovascular Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leif Carlsson Sweden 28 2.8k 2.3k 473 188 154 60 3.6k
Bernard Fermini United States 31 3.0k 1.1× 2.8k 1.2× 1.1k 2.2× 132 0.7× 102 0.7× 56 3.7k
Hua Rong Lu Belgium 28 1.6k 0.6× 1.3k 0.6× 485 1.0× 134 0.7× 159 1.0× 85 2.4k
Zhengfeng Zhou United States 28 3.1k 1.1× 3.4k 1.4× 871 1.8× 79 0.4× 102 0.7× 52 4.0k
Eva Delpón Spain 36 2.5k 0.9× 2.0k 0.9× 579 1.2× 178 0.9× 244 1.6× 139 3.6k
William Crumb United States 25 1.7k 0.6× 1.6k 0.7× 540 1.1× 68 0.4× 66 0.4× 45 2.4k
Najah Abi‐Gerges United Kingdom 30 1.5k 0.5× 1.4k 0.6× 521 1.1× 101 0.5× 106 0.7× 63 2.1k
Jordi Heijman Netherlands 33 3.7k 1.3× 1.7k 0.7× 364 0.8× 112 0.6× 294 1.9× 117 4.4k
Ricardo Caballero Spain 34 2.0k 0.7× 1.6k 0.7× 421 0.9× 106 0.6× 138 0.9× 103 2.8k
Shetuan Zhang Canada 29 1.6k 0.6× 1.8k 0.8× 518 1.1× 89 0.5× 113 0.7× 85 2.5k
Céline Fiset Canada 27 1.7k 0.6× 1.4k 0.6× 412 0.9× 85 0.5× 85 0.6× 65 2.5k

Countries citing papers authored by Leif Carlsson

Since Specialization
Citations

This map shows the geographic impact of Leif Carlsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leif Carlsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leif Carlsson more than expected).

Fields of papers citing papers by Leif Carlsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leif Carlsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leif Carlsson. The network helps show where Leif Carlsson may publish in the future.

Co-authorship network of co-authors of Leif Carlsson

This figure shows the co-authorship network connecting the top 25 collaborators of Leif Carlsson. A scholar is included among the top collaborators of Leif Carlsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leif Carlsson. Leif Carlsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vilahur, Gemma, Monika Aržanauskaitė, Soumaya Ben‐Aicha, et al.. (2024). Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction. European Heart Journal. 45(17). 1553–1567. 6 indexed citations
2.
Birnbaum, Yochai, Huan Chen, Leif Carlsson, et al.. (2022). Recombinant Apyrase (AZD3366) Against Myocardial Reperfusion Injury. Cardiovascular Drugs and Therapy. 37(4). 625–646. 6 indexed citations
3.
Correia, Cláudia, Qing‐Dong Wang, Leif Carlsson, et al.. (2021). Unraveling the Metabolic Derangements Occurring in Non-infarcted Areas of Pig Hearts With Chronic Heart Failure. Frontiers in Cardiovascular Medicine. 8. 753470–753470. 1 indexed citations
4.
5.
PEHRSSON, S. KENNETH, Bengt Kull, Marie Elebring, et al.. (2019). Abstract 11146: AZD3366-an Optimized Recombinant Human Apyrase Combining Anti Platelet, Anti Inflammatory and Tissue Protective Actions With Low Bleeding Risk for Potential Mitigation of Thromboembolic Complications. Circulation. 1 indexed citations
6.
Kajanus, Johan, Thomas Antonsson, Leif Carlsson, et al.. (2019). Potassium channel blocking 1,2-bis(aryl)ethane-1,2-diamines active as antiarrhythmic agents. Bioorganic & Medicinal Chemistry Letters. 29(10). 1241–1245. 7 indexed citations
7.
Lu, Wennan, Néstor Gómez, Jason Lim, et al.. (2018). The P2Y12 Receptor Antagonist Ticagrelor Reduces Lysosomal pH and Autofluorescence in Retinal Pigmented Epithelial Cells From the ABCA4-/- Mouse Model of Retinal Degeneration. Frontiers in Pharmacology. 9. 242–242. 18 indexed citations
8.
Sun, Naidi, Bo Ning, Kenny M. Hansson, et al.. (2018). Modified VEGF-A mRNA induces sustained multifaceted microvascular response and accelerates diabetic wound healing. Scientific Reports. 8(1). 17509–17509. 86 indexed citations
9.
Dobrev, Dobromir, Leif Carlsson, & Stanley Nattel. (2012). Novel molecular targets for atrial fibrillation therapy. Nature Reviews Drug Discovery. 11(4). 275–291. 139 indexed citations
10.
Carlsson, Leif, Göran Duker, & Ingemar Jacobson. (2010). New pharmacological targets and treatments for atrial fibrillation. Trends in Pharmacological Sciences. 31(8). 364–371. 9 indexed citations
11.
12.
Burashnikov, Alexander, José M. Di Diego, Serge Sicouri, et al.. (2008). Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation. Heart Rhythm. 5(12). 1735–1742. 50 indexed citations
13.
Carlsson, Leif, Denis Chartier, & Stanley Nattel. (2006). Characterization of the In Vivo and In Vitro Electrophysiological Effects of the Novel Antiarrhythmic Agent AZD7009 in Atrial and Ventricular Tissue of the Dog. Journal of Cardiovascular Pharmacology. 47(1). 123–132. 39 indexed citations
14.
Persson, Frida, Leif Carlsson, Göran Duker, & Ingemar Jacobson. (2005). Blocking Characteristics of hERG, hNav1.5, and hKvLQT1/hminK after Administration of the Novel Anti‐Arrhythmic Compound AZD7009. Journal of Cardiovascular Electrophysiology. 16(3). 329–341. 45 indexed citations
15.
Wu, Ying, Leif Carlsson, Tengxian Liu, Peter R. Kowey, & Gan‐Xin Yan. (2005). Assessment of the Proarrhythmic Potential of the Novel Antiarrhythmic Agent AZD7009 and Dofetilide in Experimental Models of Torsades De Pointes. Journal of Cardiovascular Electrophysiology. 16(8). 898–904. 43 indexed citations
16.
Khrestian, Celeen M., et al.. (2004). AZD7009:. Journal of Cardiovascular Electrophysiology. 15(12). 1444–1450. 79 indexed citations
17.
Carlsson, Leif, Alice Davis, W. G. Lynch, et al.. (2003). Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovascular Research. 58(1). 32–45. 1186 indexed citations breakdown →
18.
Carlsson, Leif, et al.. (1995). Prevention of Class III‐Induced Proarrhythmias by Flecainide in an Animal Model of the Acquired Long QT Syndrome. Pharmacology & Toxicology. 77(4). 250–254. 16 indexed citations
19.
Carlsson, Leif, et al.. (1993). Attenuation of proarrhythmias related to delayed repolarization by low-dose lidocaine in the anesthetized rabbit.. Journal of Pharmacology and Experimental Therapeutics. 267(3). 1076–1080. 40 indexed citations
20.
Carlsson, Leif & Tommy Abrahamsson. (1989). Ramilprilat attenuates the local release of noradrenaline in the ischemic myocardium. European Journal of Pharmacology. 166(2). 157–164. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernard Fermini Breakdown of academic impact, for papers by Hua Rong Lu Breakdown of academic impact, for papers by Zhengfeng Zhou Breakdown of academic impact, for papers by Eva Delpón Breakdown of academic impact, for papers by William Crumb Breakdown of academic impact, for papers by Najah Abi‐Gerges Breakdown of academic impact, for papers by Jordi Heijman Breakdown of academic impact, for papers by Ricardo Caballero Breakdown of academic impact, for papers by Shetuan Zhang Breakdown of academic impact, for papers by Céline Fiset
Rankless by CCL
2026